Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation

Atrial fibrillation (AF) is associated with significant risk of stroke and other thromboembolic events, which can be effectively prevented using oral anticoagulation (OAC) with either vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) dabigatran, rivaroxaban, apixaban, or edoxaban....

Descripción completa

Detalles Bibliográficos
Autores principales: Ueberham, Laura, Dagres, Nikolaos, Potpara, Tatjana S., Bollmann, Andreas, Hindricks, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656712/
https://www.ncbi.nlm.nih.gov/pubmed/28956288
http://dx.doi.org/10.1007/s12325-017-0616-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656712/
https://www.ncbi.nlm.nih.gov/pubmed/28956288
http://dx.doi.org/10.1007/s12325-017-0616-6

Ejemplares similares